Abingdon Health Announces Directorate Changes
Why we think this is neutral
This RNS announcement is a general update on directorate changes at Abingdon Health and does not contain any of the mandatory news types that would require a more detailed analysis.
Key Points
- Chris Yates steps down as CEO and Director of Abingdon Health plc, taking on the role of President of Abingdon Health USA Inc.
- Dr. Katie Brenner appointed as an Independent Non-Executive Director, effective 1 April 2025
- The Abingdon Health plc Board will comprise two Executive Directors and two Non-Executive Directors after the changes
Summary
The healthcare company announces changes to its leadership team, including the appointment of a new Non-Executive Director.
Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and distributor of rapid tests, has announced changes to its Board of Directors. Chris Yates has been appointed to the new role of President of Abingdon Health USA Inc., while Dr. Katie Brenner will join the Board as an Independent Non-Executive Director.
GENERAL UPDATE